4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-065773
President sold 15,000 shares at an average $57.93 ($868,897)
- President acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2020-12-31 | Option exercise | +15,000 | $6.32 | $94,800 | 15,000 | D |
| RUBINSTEIN JULIE President | 2020-12-31 | Sale | −7,976 | $57.56 | $459,099 | 7,024 | D |
| RUBINSTEIN JULIE President | 2020-12-31 | Sale | −6,386 | $58.25 | $371,985 | 638 | D |
| RUBINSTEIN JULIE President | 2020-12-31 | Sale | −638 | $59.27 | $37,814 | 0 | D |
| Derivatives | |||||||
| RUBINSTEIN JULIE President | 2020-12-31 | Option exercise · Stock Option (Right to Buy) | −15,000 | 380,000 | D | ||
| Open-market sales · 15,000 sh · avg $57.93 · $868,897 | |||||||
Loading xslF345X03/doc4.xml…